The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Predictive Genetic Testing And Consumer Genomics Market Progress Between 2026 And 2030?
The predictive genetic testing and consumer genomics market size has experienced significant growth in recent years. It is projected to expand from $9.07 billion in 2025 to $10.49 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.7%. The historical expansion of this market can be attributed to factors such as increased consumer health awareness, wider accessibility of genetic testing, the growing availability of affordable sequencing technologies, heightened interest in ancestry testing, and the ongoing development of digital health ecosystems.
The predictive genetic testing and consumer genomics market is anticipated to experience substantial expansion in the coming years. This market is projected to reach $18.61 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 15.4%. The drivers for this growth during the forecast period encompass a heightened need for tailored preventive healthcare, greater uptake of pharmacogenomic testing, the widening scope of consumer genomics platforms, deeper integration with digital health applications, and enhanced regulatory supervision over genetic data utilization. Key trends anticipated in the forecast period include the growing popularity of direct-to-consumer genetic testing, an uptick in the use of digital health platforms, an increasing desire for proactive health information, the proliferation of at-home sample collection solutions, and a stronger emphasis on data privacy and security.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25884&type=smp
What Leading Drivers Are Supporting The Predictive Genetic Testing And Consumer Genomics Market Expansion?
The increasing recognition of personalized medicine is set to boost the expansion of the predictive genetic testing and consumer genomics market in the future. Personalized medicine defines a medical strategy that customizes treatment and prevention approaches based on an individual’s genetic profile, lifestyle, and environmental factors. The awareness regarding personalized medicine is expanding because it enhances treatment effectiveness by aligning therapies with a patient’s distinct biological characteristics. Predictive genetic testing and consumer genomics assist personalized medicine by pinpointing genetic risks and traits, which allows for customized prevention, early diagnosis, and treatment plans tailored to an individual’s genetic profile. For instance, in February 2024, the Personalized Medicine Coalition, a US-based professional membership organization, reported that the Food and Drug Administration (FDA) approved 16 new personalized medicines in 2023, an increase from 6 in 2022. Thus, the growing understanding of personalized medicine is propelling the growth of the predictive genetic testing and consumer genomics market.
How Is Segmentation Applied In The Predictive Genetic Testing And Consumer Genomics Market Segment Analysis?
The predictive genetic testing and consumer genomics market covered in this report is segmented –
1) By Testing Type: Diagnostic Testing, Predictive Testing, Pharmacogenomic Testing, Carrier Screening
2) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray Technology, DNA Sequencing
3) By Service Type: Genetic Counseling Services, Sample Collection And Analysis, Data Interpretation And Reporting
4) By Application: Breast And Ovarian Cancer, Cardiovascular Screening, Diabetic Screening And Monitoring, Colon Cancer, Parkinsonism Or Alzheimer’s Disease, Urologic Screening Or Prostate Cancer Screening, Orthopedic And Musculoskeletal, Other Cancer Screening, Other Diseases
5) By End User: Healthcare Providers, Research Institutions, Diagnostic Laboratories, Consumers (Direct-to-Consumer Testing)
Subsegments:
1) By Diagnostic Testing: Cancer Diagnostic Testing, Neurological Disorder Testing, Rare Disease Diagnostics
2) By Predictive Testing: Cancer Risk Prediction, Cardiovascular Disease Risk, Neurodegenerative Disorder Risk
3) By Pharmacogenomic Testing: Adverse Drug Reaction Prediction, Psychiatric Medication Response, Dosage Optimization
4) By Carrier Screening: Cystic Fibrosis Carrier Screening, Sickle Cell Anemia Carrier Screening, Tay-Sachs Carrier Screening
What Emerging Trends Are Seen In The Predictive Genetic Testing And Consumer Genomics Market?
Within the predictive genetic testing and consumer genomics market, leading companies are prioritizing technological advancements, specifically high-throughput and cost-efficient sequencing, to facilitate extensive, precise, and economical genomic analysis. This type of sequencing involves rapidly processing a large volume of genomes while simultaneously lowering the cost per genome, thereby enabling population-wide testing. An example is Ultima Genomics Inc., a U.S.-based sequencing firm, which introduced its UG 100 sequencing system alongside ppmSeq extreme-accuracy mode in February 2024. This system delivers up to 6–8 billion reads per wafer, with dual-wafer operations achieving approximately 4.8 Tb and anticipated run durations under 14 hours. Featuring a wafer-based substrate and adaptable reagent cartridges, the system is designed to advance an industry-leading ~$100-genome roadmap, supported by reagent expenses of roughly $2,000 per wafer. The ppmSeq mode provides Q60 SNV raw-read accuracy without requiring extra workflow stages. Thanks to its blend of minimal reagent cost, extensive automation, and AI-powered variant calling, the UG 100 is suitable for wide-ranging uses, including consumer genomics, population screening, clinical WGS, pharmacogenomics, and large-scale research. In summary, the platform facilitates genomic data generation that is quicker, more scalable, and more economical compared to previous NGS technologies.
Who Are The Companies Participating In The Predictive Genetic Testing And Consumer Genomics Market Environment?
Major companies operating in the predictive genetic testing and consumer genomics market are Thermo Fisher Scientific Inc., Abbott Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, QIAGEN N.V., Ancestry.com, Myriad Genetics Inc., ARUP Laboratories, BGI Genomics Co. Ltd., Invitae Corporation, 23andMe Inc., Helix Inc., Color Health Inc., Mapmygenome India Ltd., Reliance Life Sciences, Dante Labs Inc., EasyDNA, Gene by Gene Ltd., Nebula Genomics Inc., Pathway Genomics Corporation
Get The Full Predictive Genetic Testing And Consumer Genomics Market Report:
Which Region Is The Top Contributor To The Predictive Genetic Testing And Consumer Genomics Market By Share?
North America was the largest region in the predictive genetic testing and consumer genomics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive genetic testing and consumer genomics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Predictive Genetic Testing And Consumer Genomics Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Predictive Genetic Testing And Consumer Genomics Market 2026, By The Business Research Company
Property Management Software Market
https://www.thebusinessresearchcompany.com/report/property-management-software-market
Property Management Service Market Report
https://www.thebusinessresearchcompany.com/report/property-management-service-global-market-report
Commercial Property Insurance Market Report
https://www.thebusinessresearchcompany.com/report/commercial-property-insurance-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model